Lv5
1180 积分 2024-10-19 加入
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
1个月前
已完结
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway
3个月前
已完结
7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo
3个月前
已完结
The gut-liver axis in liver disease: Pathophysiological basis for therapy
7个月前
已完结
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
8个月前
已完结
Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis
8个月前
已完结
A gut-vascular barrier controls the systemic dissemination of bacteria
8个月前
已完结
Wnt/β-catenin信号通路参与氧化应激的调控以及对造血系统影响的研究进展
8个月前
已完结
Mechanistic Exploration of Dahuang Zhechong Pill Against Hepatic Fibrosis via Integrated Serum Pharmacochemistry, UHPLC-ESI-QTOF-MS/MS, Network Pharmacology, and Molecular Docking with Cellular and Zebrafish Validation
11个月前
已完结
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
11个月前
已完结
皖公网安备34019202002308
